Şahin Çelik, B.; Geçgel, A.; Özkan, O.; Majidova, N.; Erkan Özmarasalı, B.; Ağdaş, G.; Bayrakçı, İ.; Evrensel, T.; Gökmen, E.
Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data. J. Clin. Med. 2025, 14, 7376.
https://doi.org/10.3390/jcm14207376
AMA Style
Şahin Çelik B, Geçgel A, Özkan O, Majidova N, Erkan Özmarasalı B, Ağdaş G, Bayrakçı İ, Evrensel T, Gökmen E.
Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data. Journal of Clinical Medicine. 2025; 14(20):7376.
https://doi.org/10.3390/jcm14207376
Chicago/Turabian Style
Şahin Çelik, Buket, Aslı Geçgel, Oğuzcan Özkan, Nargiz Majidova, Buket Erkan Özmarasalı, Gözde Ağdaş, İsmail Bayrakçı, Türkkan Evrensel, and Erhan Gökmen.
2025. "Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data" Journal of Clinical Medicine 14, no. 20: 7376.
https://doi.org/10.3390/jcm14207376
APA Style
Şahin Çelik, B., Geçgel, A., Özkan, O., Majidova, N., Erkan Özmarasalı, B., Ağdaş, G., Bayrakçı, İ., Evrensel, T., & Gökmen, E.
(2025). Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data. Journal of Clinical Medicine, 14(20), 7376.
https://doi.org/10.3390/jcm14207376